New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia

Am J Hematol. 2011 Jul;86(7):619-21. doi: 10.1002/ajh.22029. Epub 2011 Apr 20.
No abstract available

MeSH terms

  • Adult
  • Antilymphocyte Serum / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Disease-Free Survival
  • Etoposide / administration & dosage
  • Female
  • Graft vs Host Disease / mortality
  • Graft vs Host Disease / therapy
  • Humans
  • Leukemia, Myeloid, Acute / mortality*
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Stem Cell Transplantation*
  • Survival Rate
  • Thiotepa / administration & dosage
  • Time Factors
  • Transplantation Conditioning*
  • Transplantation, Homologous
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Antilymphocyte Serum
  • Etoposide
  • Thiotepa
  • Vidarabine
  • fludarabine